ima-026
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00517348)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Interleukin-13INHIBITOR
IL13 inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594477 ↗
Also known as
- ima-026
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00725582 | Phase 1 | Sep 1, 2008 | Pfizer, Wyeth |
| NCT00528099 | Phase 1 | Oct 1, 2007 | Pfizer, Wyeth |
| NCT00517348 | Phase 1 | Sep 1, 2007 | Pfizer, Wyeth |
Showing 3 of 3 trials
Page 1 / 1